 James Orth
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 7 | 2018 | 597 | 1.480 |
Why?
| | Karyopherins | 2 | 2018 | 20 | 1.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 209 | 0.970 |
Why?
| | Cell Tracking | 2 | 2016 | 16 | 0.970 |
Why?
| | Mitosis | 6 | 2011 | 196 | 0.890 |
Why?
| | Hydrazines | 3 | 2018 | 37 | 0.740 |
Why?
| | DNA Damage | 2 | 2017 | 427 | 0.730 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2018 | 528 | 0.700 |
Why?
| | Triazoles | 3 | 2018 | 157 | 0.680 |
Why?
| | Antineoplastic Agents | 7 | 2018 | 2166 | 0.610 |
Why?
| | Cell Cycle Checkpoints | 3 | 2018 | 97 | 0.600 |
Why?
| | Apoptosis | 5 | 2018 | 2574 | 0.560 |
Why?
| | Antimitotic Agents | 4 | 2011 | 8 | 0.540 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2025 | 161 | 0.520 |
Why?
| | Endocytosis | 3 | 2006 | 175 | 0.510 |
Why?
| | Time-Lapse Imaging | 1 | 2016 | 22 | 0.490 |
Why?
| | Tubulin Modulators | 3 | 2014 | 10 | 0.490 |
Why?
| | Single-Cell Analysis | 3 | 2016 | 338 | 0.470 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2025 | 403 | 0.430 |
Why?
| | Cell Line, Tumor | 9 | 2020 | 3469 | 0.420 |
Why?
| | Cell Death | 4 | 2017 | 386 | 0.400 |
Why?
| | Paclitaxel | 4 | 2011 | 237 | 0.370 |
Why?
| | Molecular Chaperones | 3 | 2025 | 198 | 0.370 |
Why?
| | Dynamins | 5 | 2006 | 38 | 0.370 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 898 | 0.330 |
Why?
| | Neoplasms | 9 | 2020 | 2741 | 0.330 |
Why?
| | Microscopy | 3 | 2016 | 156 | 0.290 |
Why?
| | Saccharomyces cerevisiae | 2 | 2025 | 556 | 0.270 |
Why?
| | Cell Surface Extensions | 3 | 2004 | 14 | 0.270 |
Why?
| | Actins | 5 | 2005 | 423 | 0.260 |
Why?
| | Cell Survival | 4 | 2018 | 1129 | 0.240 |
Why?
| | ErbB Receptors | 2 | 2006 | 610 | 0.240 |
Why?
| | Phenotype | 2 | 2015 | 3166 | 0.230 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2006 | 231 | 0.220 |
Why?
| | Proteolysis | 2 | 2025 | 175 | 0.200 |
Why?
| | Eukaryotic Cells | 1 | 2003 | 40 | 0.190 |
Why?
| | Microfilament Proteins | 4 | 2005 | 132 | 0.190 |
Why?
| | Actin Cytoskeleton | 1 | 2003 | 103 | 0.190 |
Why?
| | GTP Phosphohydrolases | 1 | 2002 | 93 | 0.180 |
Why?
| | Spindle Apparatus | 3 | 2010 | 103 | 0.170 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2020 | 830 | 0.170 |
Why?
| | Benzoxazoles | 1 | 2020 | 19 | 0.160 |
Why?
| | Microscopy, Fluorescence | 5 | 2014 | 417 | 0.160 |
Why?
| | Azepines | 1 | 2020 | 97 | 0.160 |
Why?
| | G1 Phase | 1 | 2018 | 72 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 66 | 0.140 |
Why?
| | Cell Movement | 2 | 2003 | 990 | 0.140 |
Why?
| | Imidazoles | 1 | 2018 | 244 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2017 | 2064 | 0.130 |
Why?
| | Pyrimidines | 1 | 2020 | 477 | 0.130 |
Why?
| | Cell Lineage | 1 | 2018 | 350 | 0.130 |
Why?
| | HeLa Cells | 5 | 2011 | 640 | 0.120 |
Why?
| | Piperazines | 1 | 2018 | 354 | 0.120 |
Why?
| | Dynamin II | 2 | 2005 | 4 | 0.120 |
Why?
| | DNA Replication | 1 | 2017 | 240 | 0.120 |
Why?
| | Humans | 20 | 2020 | 141187 | 0.120 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2015 | 122 | 0.110 |
Why?
| | Furans | 1 | 2014 | 24 | 0.110 |
Why?
| | Isoquinolines | 1 | 2014 | 44 | 0.110 |
Why?
| | Benzopyrans | 1 | 2014 | 27 | 0.110 |
Why?
| | Tetrazoles | 1 | 2014 | 44 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2015 | 174 | 0.110 |
Why?
| | Ketones | 1 | 2014 | 51 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 914 | 0.110 |
Why?
| | RNA Interference | 3 | 2011 | 469 | 0.110 |
Why?
| | Animals | 15 | 2020 | 37657 | 0.110 |
Why?
| | Cortactin | 4 | 2006 | 7 | 0.110 |
Why?
| | Quinolines | 2 | 2011 | 160 | 0.100 |
Why?
| | Fluorescent Dyes | 1 | 2015 | 324 | 0.100 |
Why?
| | Mice, Nude | 2 | 2014 | 691 | 0.100 |
Why?
| | Protein Binding | 2 | 2017 | 2239 | 0.090 |
Why?
| | Mice | 8 | 2020 | 18048 | 0.090 |
Why?
| | Deoxyribonucleases | 1 | 2011 | 24 | 0.090 |
Why?
| | Holoenzymes | 2 | 2022 | 25 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1787 | 0.080 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 854 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2010 | 626 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2003 | 859 | 0.080 |
Why?
| | Transfection | 3 | 2014 | 943 | 0.080 |
Why?
| | Amino Acid Sequence | 4 | 2006 | 2158 | 0.080 |
Why?
| | Cell Cycle Proteins | 2 | 2010 | 624 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2929 | 0.070 |
Why?
| | Fibroblasts | 2 | 2006 | 1020 | 0.070 |
Why?
| | Chromosome Segregation | 1 | 2008 | 47 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 3 | 2014 | 672 | 0.070 |
Why?
| | Cell Membrane | 3 | 2006 | 724 | 0.070 |
Why?
| | Cell Line | 6 | 2014 | 2885 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2009 | 315 | 0.070 |
Why?
| | Genome, Human | 1 | 2009 | 420 | 0.070 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 159 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 278 | 0.060 |
Why?
| | COS Cells | 1 | 2006 | 183 | 0.060 |
Why?
| | Epidermal Growth Factor | 1 | 2006 | 176 | 0.060 |
Why?
| | Caveolins | 1 | 2005 | 6 | 0.060 |
Why?
| | Microtubules | 1 | 2008 | 285 | 0.060 |
Why?
| | ADP-Ribosylation Factor 1 | 1 | 2005 | 5 | 0.060 |
Why?
| | Nuclear Localization Signals | 1 | 2025 | 18 | 0.060 |
Why?
| | Green Fluorescent Proteins | 2 | 2009 | 400 | 0.060 |
Why?
| | Golgi Apparatus | 1 | 2005 | 100 | 0.060 |
Why?
| | Quality Control | 1 | 2025 | 171 | 0.060 |
Why?
| | Cryptosporidium parvum | 1 | 2004 | 13 | 0.050 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2004 | 22 | 0.050 |
Why?
| | Cytoplasm | 1 | 2025 | 273 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 368 | 0.050 |
Why?
| | Coated Pits, Cell-Membrane | 1 | 2003 | 3 | 0.050 |
Why?
| | Cell Size | 1 | 2003 | 89 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2003 | 93 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 156 | 0.050 |
Why?
| | Rats | 4 | 2005 | 5629 | 0.050 |
Why?
| | Microscopy, Video | 1 | 2002 | 26 | 0.050 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 46 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2025 | 609 | 0.050 |
Why?
| | Models, Biological | 3 | 2009 | 1828 | 0.050 |
Why?
| | Phosphorylation | 1 | 2006 | 1768 | 0.040 |
Why?
| | Proline | 1 | 2002 | 76 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2002 | 181 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2504 | 0.040 |
Why?
| | Hepatocytes | 1 | 2002 | 211 | 0.040 |
Why?
| | Plasmids | 1 | 2002 | 365 | 0.040 |
Why?
| | Cdc20 Proteins | 2 | 2010 | 4 | 0.040 |
Why?
| | Aurora Kinase A | 1 | 2020 | 55 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 601 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 62 | 0.040 |
Why?
| | Maximum Tolerated Dose | 1 | 2020 | 206 | 0.040 |
Why?
| | Time Factors | 3 | 2009 | 6956 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 492 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 129 | 0.040 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 324 | 0.040 |
Why?
| | Mutation | 3 | 2009 | 4013 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2015 | 772 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2006 | 882 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1737 | 0.030 |
Why?
| | Models, Molecular | 1 | 2022 | 1603 | 0.030 |
Why?
| | Signal Transduction | 2 | 2006 | 5144 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1431 | 0.030 |
Why?
| | Microscopy, Immunoelectron | 2 | 2005 | 45 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 107 | 0.030 |
Why?
| | Microinjections | 2 | 2005 | 86 | 0.030 |
Why?
| | Drug Carriers | 1 | 2014 | 126 | 0.030 |
Why?
| | Macromolecular Substances | 2 | 2005 | 226 | 0.030 |
Why?
| | Cytoskeleton | 2 | 2003 | 194 | 0.020 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 11 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2011 | 33 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2011 | 38 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2011 | 75 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 194 | 0.020 |
Why?
| | Cyclin B1 | 1 | 2009 | 6 | 0.020 |
Why?
| | Nocodazole | 1 | 2009 | 17 | 0.020 |
Why?
| | Cyclin B | 1 | 2009 | 16 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2009 | 41 | 0.020 |
Why?
| | Permeability | 1 | 2009 | 166 | 0.020 |
Why?
| | Nanoparticles | 1 | 2014 | 480 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1234 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 1003 | 0.020 |
Why?
| | HT29 Cells | 1 | 2008 | 41 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 236 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2008 | 80 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 623 | 0.020 |
Why?
| | Epithelial Cells | 2 | 2004 | 1110 | 0.020 |
Why?
| | Caspases | 1 | 2008 | 245 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2009 | 464 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 959 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 47 | 0.010 |
Why?
| | Caveolin 1 | 1 | 2005 | 22 | 0.010 |
Why?
| | Models, Statistical | 1 | 2009 | 671 | 0.010 |
Why?
| | Peptide Mapping | 1 | 2005 | 65 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2011 | 1154 | 0.010 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 361 | 0.010 |
Why?
| | Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2004 | 2 | 0.010 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2004 | 4 | 0.010 |
Why?
| | Osteoclasts | 1 | 2004 | 51 | 0.010 |
Why?
| | Pseudopodia | 1 | 2004 | 27 | 0.010 |
Why?
| | Biliary Tract Diseases | 1 | 2004 | 33 | 0.010 |
Why?
| | Cryptosporidiosis | 1 | 2004 | 22 | 0.010 |
Why?
| | rho GTP-Binding Proteins | 1 | 2004 | 60 | 0.010 |
Why?
| | Protein Transport | 1 | 2005 | 448 | 0.010 |
Why?
| | Actin-Related Protein 3 | 1 | 2003 | 1 | 0.010 |
Why?
| | Clathrin | 1 | 2003 | 26 | 0.010 |
Why?
| | Transferrin | 1 | 2003 | 50 | 0.010 |
Why?
| | src Homology Domains | 1 | 2003 | 38 | 0.010 |
Why?
| | Host-Parasite Interactions | 1 | 2004 | 118 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2005 | 265 | 0.010 |
Why?
| | Dextrans | 1 | 2003 | 85 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 2003 | 113 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 274 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 579 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1764 | 0.010 |
Why?
| | Aged | 1 | 2020 | 24574 | 0.010 |
Why?
| | Female | 2 | 2020 | 75515 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 34434 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2005 | 4208 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1448 | 0.010 |
Why?
| | Liver | 1 | 2003 | 1819 | 0.010 |
Why?
| | Male | 1 | 2020 | 69783 | 0.010 |
Why?
|
|
Orth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|